Insider buying · SEC Form 4

Insider Buying — Aug 19, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

8insider buys
$7.20Mbought in total
6companies
3by CEOs, CFOs and other chiefs
ONONlargest: $1.99M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
ONONOn Holding AGCaspar Felix CoppettiExecutive Officer & Co-CEO$1.99M65,000$30.67AddedAug 17, 2026
Form 4 ↗
Bought 65,000 Class A shares at $30.6737 weighted avg (range $30.57–$30.78) on Aug 14, 2026. Same-day purchase as Co-CEO Olivier Bernhard. ONON dropped 20%+ post-Q2 earnings miss before this buy. Post-transaction holdings: 2,440,855 shares. No 10b5-1 plan.
ONONOn Holding AGOlivier BernhardExecutive Officer$1.99M65,000$30.67AddedAug 17, 2026
Form 4 ↗
Bought 65,000 Class A shares at $30.6737 weighted avg (range $30.57–$30.78) on Aug 14, 2026. Same-day purchase as Co-CEO Coppetti. Post-transaction holdings: 5,228,184 shares. Cluster buy signal: both founders purchasing simultaneously.
BFLYButterfly Network, Inc.Louise S. PhanstielDirector$999K115,200$8.67AddedAug 17, 2026
Form 4 ↗
Bought 115,200 Class A shares at $8.6763 weighted avg (range $8.49–$8.865) on Aug 14, 2026, via The Phanstiel Trust. Post-transaction: 300,461 indirect + 390,952 direct shares. No 10b5-1 plan.
MLABMesa Laboratories, Inc.Siddhartha KadiaPresident and CEO$800K7,093$112.80AddedAug 17, 2026
Form 4 ↗
Acquired 7,093 shares at $112.80/share on Aug 13, 2026 — NOTE: this was a privately negotiated purchase from Board Chair John Sullivan, NOT an open-market transaction. Purchased via Anjou Parekh Lifetime Access Trust (spouse as trustee).
ASNDAscendis Pharma A/SJean Jacques BienaiméDirector$493K2,000$246.33AddedAug 18, 2026
Form 4 ↗
Two open-market purchases on Aug 14: 1,100 shares at $245.85 avg ($270,435) and 900 shares at $246.91 avg ($222,219). Total 2,000 shares at ~$246.38 avg. Post-transaction: 2,900 direct shares. No 10b5-1 plan.
REZIResideo Technologies, Inc.Joshua Peter FosterSVP, General Counsel & Corporate Secretary$315K15,317$20.58AddedAug 17, 2026
Form 4 ↗
Bought 15,317 shares at approximately $20.58 avg in open-market transaction. Cluster buy alongside CEO Thomas Surran within same week. Resideo is a home comfort and security technology company.
REZIResideo Technologies, Inc.Thomas A SurranPresident and CEO$307K15,000$20.46AddedAug 17, 2026
Form 4 ↗
Bought 15,000 shares at $20.46 weighted avg (range $20.41–$20.47) on Aug 14, 2026. Post-transaction: 338,573 direct shares. Cluster buy: CEO + SVP GC both purchasing near identical prices.
ENHAEnhanced Group Inc.Apeiron Investment Group Ltd.10% Owner$296K150,000$1.97AddedAug 17, 2026
Form 4 ↗
Apeiron Investment Group (European family office) bought 150,000 shares at approximately $1.97 avg. Currently −17.3% below buy price. Small-cap, limited liquidity — treat as speculative.

AIThe day in insider buying

SEC Form 4 Insider Scan — August 19, 2026

Scanned EDGAR Form 4 filings filed August 17–18, 2026 (48-hour window; most transactions executed Aug 13–14). 8 qualifying buys (≥ $250K, transaction type P) across 6 companies, totalling $7.2M.

Headline Filings

  • ONON — Caspar Felix Coppetti (Co-CEO & Founder) bought 65,000 shares ≈ $1.99M at $30.67 avg; now $31.03 (+1.2% since buy). (filing) Cluster: both co-CEOs buying same day
  • ONON — Olivier Bernhard (Executive Officer & Co-CEO) bought 65,000 shares ≈ $1.99M at $30.67 avg; now $31.03 (+1.2% since buy). (filing) Combined founders committed ~$4M post-earnings selloff
  • BFLY — Louise S. Phanstiel (Director) bought 115,200 shares ≈ $999K at $8.68 avg via Phanstiel Trust; now $9.00 (+3.7% since buy). (filing)
  • MLAB — Siddhartha Kadia (President & CEO) acquired 7,093 shares ≈ $800K at $112.80 (private purchase from Board Chair John Sullivan — not an open-market transaction); now $107.94 (−4.3% since buy). (filing)
  • ASND — Jean Jacques Bienaimé (Director) bought 2,000 shares ≈ $493K at $246.38 avg (filed Aug 18); now $248.85 (+1.0% since buy). (filing)
  • REZI — Joshua Peter Foster (SVP, GC & Corp Sec) bought 15,317 shares ≈ $315K at $20.58 avg; now $21.02 (+2.1% since buy). (filing)
  • REZI — Thomas A Surran (President & CEO) bought 15,000 shares ≈ $307K at $20.46; now $21.02 (+2.7% since buy). (filing) Cluster: CEO + SVP both buying within same week
  • ENHA — Apeiron Investment Group Ltd (10% Owner) bought 150,000 shares ≈ $296K at $1.97 avg; now $1.63 (−17.3% since buy). (filing)

Notes

On Holding (ONON) dominates this scan with the largest combined value (~$4.0M) and the most conviction signal: both founders and Co-CEOs purchased on August 14, the exact same day, after ONON dropped 20%+ on Q2 results that missed expectations. Classic "founders buy the dip" when they have superior knowledge of the business trajectory. ONON is currently +1.2% above the purchase price with the stock stabilizing.

Resideo Technologies (REZI) shows a CEO + SVP cluster buy, with both executives transacting independently at nearly identical price levels ($20.46–$20.58). Resideo is an IoT and home comfort/security technology company that recently underwent leadership transition; this coordinated buying often signals internal conviction about upcoming catalysts.

Butterfly Network (BFLY) director Phanstiel committed ~$1M through her family trust at $8.68 — a high-conviction buy for a medical device AI ultrasound company near its recent lows. Now 3.7% in the green.

Ascendis Pharma (ASND) director Bienaimé is adding to a small existing position, buying rare disease biotech shares around $246 — notable given the company's strong pipeline momentum.

Mesa Labs (MLAB) purchase was a privately negotiated transaction (CEO buying from Board Chair, not open market) — flagged for transparency. Less of a market-signal than standard open-market buys.

ENHA is currently underwater 17% since the Apeiron buy — small-cap risk with limited liquidity. Treat with caution.

Most-bought stocks, last 30 days

  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $56.2M · 7 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • LBRX $10.0M · 1 buyLB Pharmaceuticals Inc.
  • BSX $9.00M · 1 buyBoston Scientific Corp
  • ONON $7.98M · 4 buys, 3 insidersOn Holding AG
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • APMD $5.00M · 1 buyApnimed, Inc.
  • BLSM $5.00M · 1 buyBlossomHill Therapeutics, Inc.
  • GSHD $4.49M · 3 buysGoosehead Insurance, Inc.
  • BORR $4.39M · 2 buysBorr Drilling Ltd
  • TXO $3.58M · 2 buysTXO Partners, L.P.
  • LILA $2.90M · 1 buyLiberty Latin America Ltd.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • LTGO $2.52M · 1 buyLatigo Biotherapeutics, Inc.
  • APTV $2.50M · 1 buyAptiv PLC
  • CSGP $2.49M · 1 buyCoStar Group, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • NATR $2.32M · 1 buyNature's Sunshine Products, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.